Cardiac Issues Associated with High-Dose Drug Trial

Last week, Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced they were ending the higher-dose portions of two multiple-sclerosis medication studies. The decision came after eight patients suffered nonfatal… Read More

Inquiry Roundup- Medical Devices

Medical Image Processing I am working on a project that aims to measure optical density ratio’s in images obtained from a very popular eye device names Optical Coherence Tomography (OCT),… Read More

Teva Halts Studies for Multiple Sclerosis Drug

Teva Pharmaceutical Industries Ltd. and Active Biotech AB recently announced changes to two current drug studies after eight patients suffered “nonfatal cardiovascular events” during ¬†phases 2 and 3 of a… Read More

Inquiry Roundup – Construction

Hospital EPC We are an authorized Zintro partner and are seeking to connect with experts who can comment on certain facets relating Hospital engineering, procurement and construction (EPC) globally. View… Read More

Inquiry roundup- Medical Devices.

Medical Device Marketing I am looking for a Marketing expert on Medical Device Business. View Inquiry Ultrasound Imaging I am seeking experts with experience and market knowledge regarding ultrasound-guided needle… Read More

Premature Babies to Benefit from 3-D Printing Technology

We spoke with Zintro expert Scott Bork in August about the FDA approval of Spritam, the first 3D printed drug, designed to treat seizures brought on by epilepsy in children… Read More

Google Life Sciences Targeting Diabetes–Part II

Last month, Zintro experts responded to the September announcement by Google Life Sciences that it’s researching new therapies to improve diabetes care in collaboration with French multinational pharmaceutical company Sanofi…. Read More

European Life Sciences Companies Turn to Crowdfunding

According to a new report, European life science companies are finding crowdfunding to be a good means of raising quick cash, if not a replacement for angels or VCs. ‘Analysis… Read More

What Does Zarxio Launch Mean for the Future of Biosimilar Drugs?

Last month, Novartis kicked off a new era in U.S. medicine, launching Zarxio, a biosimilar copy of Neupogen–Amgen’s white blood cell-boosting drug. Zarxio is the first biosimilar copy of a… Read More

First Up for Google Life Sciences–Tackling Diabetes

Last month, Google announced that it was creating a new holding company called Alphabet and spinning off all non-core activities from the Google brand–including life sciences work inside Google X…. Read More

Inquiry Roundup- Medical Reimbursement

Us Medical Insurance We are an authorized Zintro partner interested in connecting with executive payors with the following top US Medical Insurance Companies: United Health Group Humana Aetna Cigna Blue… Read More

Ebola Vaccine Begins Distribution

Last month, preliminary results on an Ebola vaccine in Guinea suggested it was 100 percent effective against the disease. As a result, Doctors Without Borders began to recommend distribution of… Read More

FDA Extends Compliance Date for Menu-Labeling Rule

Last month, the FDA extended the compliance date for its controversial menu-labeling rule from Dec. 1, 2015 to Dec. 1, 2016. The new requirements apply to restaurants and similar retail… Read More

FDA Approves First 3D Printed Drug

The U.S. Food and Drug Administration (FDA) approved the first 3D-printed drug this month, Spritam, designed to treat seizures brought on by epilepsy in children and adults. It was developed… Read More

Inquiry Roundup-Drug Formulation

Regional Drug Delivery Device Require an expert with extensive knowledge of regional drug delivery device markets to help identify suppliers who can manufacture electronic drug delivery devices (smart inhalers, nebulizers,… Read More

Crop Biotechnology Impact on Developing Countries Part 1

According to an annual report from PG Economics, farmers in developing countries can benefit from GMO crops, particularly corn, soybeans, cotton, and canola. The report–GM crops: global socio-economic and environmental… Read More